BYOT.L Regulatory News (BYOT)

26 Oct 2006 10:24

Byotrol PLC26 October 2006 BYOTROL PLC DISTRIBUTION AGREEMENTS SIGNED FOR HEALTHCARE SECTOR The Directors of Byotrol plc (the "Company") are pleased to announce that theCompany has entered into two separate distribution agreements with SunChoiceEurope Limited ("SunChoice") and DBM Holdings Ltd ("DBM") to supply Byotrol'sassure product range into the UK care homes market. SunChoice distributes an extensive range of over 5000 products to more than1,000 nursing and residential care homes in the UK. The product range includescleaning and janitorial products, medical consumables, uniforms and patienthandling equipment. SunChoice is wholly owned by Southern Cross Healthcare Groupplc, the largest provider of care homes and long term care beds in the UK, whichoperates over 570 care homes, providing more than 28,000 beds and employingaround 33,000 staff. Based in Edinburgh, DBM supplies products to healthcare and retail markets, witha particular focus on independent care home operators throughout the UK. Byotrol's assure range has been specifically developed for the care homes sectorand comprises disinfectant sprays for use in living areas, kitchens andbathrooms, cleaning and sanitising wipes, and a hand sanitising mousse. TheCompany's patented technology has been proven, through extensive testing, to beeffective in eradicating and controlling a wide range of organisms such as MRSA,c.difficile and e-coli. Byotrol remains active after it has dried, providinganti-microbial protection for extended periods after application and is abletherefore to tackle the practical problems of odours and spoilage caused bymicrobe activity. Byotrol is not toxic to humans and does not require any specialist equipment oralteration to existing cleaning regimens to be effective. A further advantage ofByotrol is also its ultra low alcohol content, compared to competing products,which means it does not dry or irritate the skin when used as a hand sanitiseras part of infection control procedures. The Directors anticipate that the agreements with SunChoice and DBM will make asignificant contribution to the Company's future revenues. Stephen Falder, Byotrol's Deputy Chairman commented: "We are delighted to be working with SunChoice and DBM, who will be marketingour assure product range to a significant number of nursing and residential carehomes in the UK. Byotrol has undergone extensive testing and has been shown todeliver substantial benefits to both residents and healthcare professionals ." Barbara Hornby, Managing Director for SunChoice Europe commented: "Working with Byotrol is a significant move for SunChoice Europe to provide aleading edge, yet proven solution for infection control. We now have theopportunity to distribute this innovative technology to care homes across theUK, helping to combat the risk and spread of MRSA and other harmfulmicro-organisms." Gary Walsh, Marketing Director for DBM stated: "The partnership with Byotrol enables DBM to provide truly innovative controlmethods which are safe to use, compatible with the material they protect andalso comply with increasingly strict regulatory controls. This ground breakinganti microbial technology will provide care and nursing homes with a trulyunique method of combating the risk and spread of MRSA and other harmfulmicro-organisms in higher risk environments. We also believe that the resultsof the recent study at Glasgow Royal Infirmary will have a positive impact onpotential customers." 26 October 2006 Enquiries: Byotrol plc 0161 277 9518 Stephen FalderDeputy Chairman David McRobbieChief Executive Charles Stanley Securities 020 7149 6457 Philip Davies First City PR 0207 436 7486 Allan Piper McCann Erickson PR 01625 822540 Jim Rothnie This information is provided by RNS The company news service from the London Stock Exchange